Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 100

1.

Hyaline fibrous involution of breast lobules: a histologic finding associated with germline BRCA mutation.

Lee HE, Arshad M, Brahmbhatt RD, Hoskin TL, Winham SJ, Frost MH, Radisky DC, Denison LA, Degnim AC, Visscher DW.

Mod Pathol. 2019 Apr 17. doi: 10.1038/s41379-019-0217-9. [Epub ahead of print]

PMID:
30996252
2.

Evaluation of 2 breast cancer risk models in a benign breast disease cohort.

Frank RD, Winham SJ, Vierkant RA, Frost MH, Radisky DC, Ghosh K, Brandt KR, Sherman ME, Visscher DW, Hartmann LC, Degnim AC, Vachon CM.

Cancer. 2018 Aug;124(16):3319-3328. doi: 10.1002/cncr.31528. Epub 2018 Jun 22.

PMID:
29932456
3.

Model for Predicting Breast Cancer Risk in Women With Atypical Hyperplasia.

Degnim AC, Winham SJ, Frank RD, Pankratz VS, Dupont WD, Vierkant RA, Frost MH, Hoskin TL, Vachon CM, Ghosh K, Hieken TJ, Carter JM, Denison LA, Broderick B, Hartmann LC, Visscher DW, Radisky DC.

J Clin Oncol. 2018 Jun 20;36(18):1840-1846. doi: 10.1200/JCO.2017.75.9480. Epub 2018 Apr 20.

4.

Association between mammographic breast density and histologic features of benign breast disease.

Ghosh K, Vierkant RA, Frank RD, Winham S, Visscher DW, Pankratz VS, Scott CG, Brandt K, Sherman ME, Radisky DC, Frost MH, Hartmann LC, Degnim AC, Vachon CM.

Breast Cancer Res. 2017 Dec 19;19(1):134. doi: 10.1186/s13058-017-0922-6.

5.

Macrophagic "Crown-like Structures" Are Associated with an Increased Risk of Breast Cancer in Benign Breast Disease.

Carter JM, Hoskin TL, Pena MA, Brahmbhatt R, Winham SJ, Frost MH, Stallings-Mann M, Radisky DC, Knutson KL, Visscher DW, Degnim AC.

Cancer Prev Res (Phila). 2018 Feb;11(2):113-119. doi: 10.1158/1940-6207.CAPR-17-0245. Epub 2017 Nov 22.

6.

CD56+ immune cell infiltration and MICA are decreased in breast lobules with fibrocystic changes.

Kerekes D, Visscher DW, Hoskin TL, Radisky DC, Brahmbhatt RD, Pena A, Frost MH, Arshad M, Stallings-Mann M, Winham SJ, Murphy L, Denison L, Carter JM, Knutson KL, Degnim AC.

Breast Cancer Res Treat. 2018 Feb;167(3):649-658. doi: 10.1007/s10549-017-4558-0. Epub 2017 Nov 1.

7.

NanoString-based breast cancer risk prediction for women with sclerosing adenosis.

Winham SJ, Mehner C, Heinzen EP, Broderick BT, Stallings-Mann M, Nassar A, Vierkant RA, Hoskin TL, Frank RD, Wang C, Denison LA, Vachon CM, Frost MH, Hartmann LC, Aubrey Thompson E, Sherman ME, Visscher DW, Degnim AC, Radisky DC.

Breast Cancer Res Treat. 2017 Nov;166(2):641-650. doi: 10.1007/s10549-017-4441-z. Epub 2017 Aug 10.

8.

Postlactational involution biomarkers plasminogen and phospho-STAT3 are linked with active age-related lobular involution.

Stallings-Mann ML, Heinzen EP, Vierkant RA, Winham SJ, Hoskin TL, Denison LA, Nassar A, Hartmann LC, Visscher DW, Frost MH, Sherman ME, Degnim AC, Radisky DC.

Breast Cancer Res Treat. 2017 Nov;166(1):133-143. doi: 10.1007/s10549-017-4413-3. Epub 2017 Jul 27.

9.

Breast Cancer Risk and Progressive Histology in Serial Benign Biopsies.

Visscher DW, Frank RD, Carter JM, Vierkant RA, Winham SJ, Heinzen EP, Broderick BT, Denison LA, Allers TM, Johnson JL, Frost MH, Hartmann LC, Degnim AC, Radisky DC.

J Natl Cancer Inst. 2017 Oct 1;109(10). doi: 10.1093/jnci/djx035.

10.

Aromatase expression in atypical ductal hyperplasia in women.

Santen RJ, Radisky DC, Degnim A, Frost MH, Vachon CM, Ghosh K, Guestini F, McNamara KM, Sasano H.

Breast Cancer Res Treat. 2017 Jun;163(3):623-629. doi: 10.1007/s10549-017-4184-x. Epub 2017 Mar 23.

PMID:
28337664
11.

Mammographic breast density and risk of breast cancer in women with atypical hyperplasia: an observational cohort study from the Mayo Clinic Benign Breast Disease (BBD) cohort.

Vierkant RA, Degnim AC, Radisky DC, Visscher DW, Heinzen EP, Frank RD, Winham SJ, Frost MH, Scott CG, Jensen MR, Ghosh K, Manduca A, Brandt KR, Whaley DH, Hartmann LC, Vachon CM.

BMC Cancer. 2017 Jan 31;17(1):84. doi: 10.1186/s12885-017-3082-2.

12.

Alterations in the Immune Cell Composition in Premalignant Breast Tissue that Precede Breast Cancer Development.

Degnim AC, Hoskin TL, Arshad M, Frost MH, Winham SJ, Brahmbhatt RA, Pena A, Carter JM, Stallings-Mann ML, Murphy LM, Miller EE, Denison LA, Vachon CM, Knutson KL, Radisky DC, Visscher DW.

Clin Cancer Res. 2017 Jul 15;23(14):3945-3952. doi: 10.1158/1078-0432.CCR-16-2026. Epub 2017 Jan 26.

13.

Factors Associated With Poor Outcome in Childhood Swimming Pool Submersions.

Shenoi RP, Koerner CE, Cruz AT, Frost MH, Jones JL, Camp EA, Alam S, Fraser JJ Jr.

Pediatr Emerg Care. 2016 Oct;32(10):669-674.

PMID:
26999583
14.

Standardized measures of lobular involution and subsequent breast cancer risk among women with benign breast disease: a nested case-control study.

Figueroa JD, Pfeiffer RM, Brinton LA, Palakal MM, Degnim AC, Radisky D, Hartmann LC, Frost MH, Stallings Mann ML, Papathomas D, Gierach GL, Hewitt SM, Duggan MA, Visscher D, Sherman ME.

Breast Cancer Res Treat. 2016 Aug;159(1):163-72. doi: 10.1007/s10549-016-3908-7. Epub 2016 Aug 3.

15.

Extent of atypical hyperplasia stratifies breast cancer risk in 2 independent cohorts of women.

Degnim AC, Dupont WD, Radisky DC, Vierkant RA, Frank RD, Frost MH, Winham SJ, Sanders ME, Smith JR, Page DL, Hoskin TL, Vachon CM, Ghosh K, Hieken TJ, Denison LA, Carter JM, Hartmann LC, Visscher DW.

Cancer. 2016 Oct;122(19):2971-8. doi: 10.1002/cncr.30153. Epub 2016 Jun 28.

16.

Breast cancer risk by the extent and type of atypical hyperplasia.

Degnim AC, Visscher DW, Radisky DC, Frost MH, Vierkant RA, Frank RD, Winham SJ, Vachon CM, Dupont WD, Hartmann LC.

Cancer. 2016 Oct;122(19):3087-8. doi: 10.1002/cncr.30151. Epub 2016 Jun 28. No abstract available.

17.

Natural history of age-related lobular involution and impact on breast cancer risk.

Radisky DC, Visscher DW, Frank RD, Vierkant RA, Winham S, Stallings-Mann M, Hoskin TL, Nassar A, Vachon CM, Denison LA, Hartmann LC, Frost MH, Degnim AC.

Breast Cancer Res Treat. 2016 Feb;155(3):423-30. doi: 10.1007/s10549-016-3691-5. Epub 2016 Feb 4.

18.

Mucocele-like lesions of the breast: a clinical outcome and histologic analysis of 102 cases.

Meares AL, Frank RD, Degnim AC, Vierkant RA, Frost MH, Hartmann LC, Winham SJ, Visscher DW.

Hum Pathol. 2016 Mar;49:33-8. doi: 10.1016/j.humpath.2015.10.004. Epub 2015 Oct 31.

19.

Clinicopathologic features of breast cancers that develop in women with previous benign breast disease.

Visscher DW, Frost MH, Hartmann LC, Frank RD, Vierkant RA, McCullough AE, Winham SJ, Vachon CM, Ghosh K, Brandt KR, Farrell AM, Tarabishy Y, Hieken TJ, Haddad TC, Kraft RA, Radisky DC, Degnim AC.

Cancer. 2016 Feb 1;122(3):378-85. doi: 10.1002/cncr.29766. Epub 2015 Oct 29.

20.

Improving Spiritual Well-Being in Patients with Lung Cancers.

Piderman KM, Sytsma TT, Frost MH, Novotny PJ, Rausch Osian SM, Solberg Nes L, Patten CA, Sloan JA, Rummans TA, Bronars CA, Yang P, Clark MM.

J Pastoral Care Counsel. 2015 Sep;69(3):156-62. doi: 10.1177/1542305015602711.

21.

Breast cancer after prophylactic mastectomy (bilateral or contralateral prophylactic mastectomy), a clinical entity: presentation, management, and outcomes.

Mutter RW, Frost MH, Hoskin TL, Johnson JL, Hartmann LC, Boughey JC.

Breast Cancer Res Treat. 2015 Aug;153(1):183-90. doi: 10.1007/s10549-015-3515-z. Epub 2015 Jul 26.

PMID:
26210521
22.

Gene signature model for breast cancer risk prediction for women with sclerosing adenosis.

Degnim AC, Nassar A, Stallings-Mann M, Keith Anderson S, Oberg AL, Vierkant RA, Frank RD, Wang C, Winham SJ, Frost MH, Hartmann LC, Visscher DW, Radisky DC.

Breast Cancer Res Treat. 2015 Aug;152(3):687-94. doi: 10.1007/s10549-015-3513-1. Epub 2015 Jul 23.

23.

Ki-67 expression in sclerosing adenosis and adjacent normal breast terminal ductal lobular units: a nested case-control study from the Mayo Benign Breast Disease Cohort.

Nassar A, Hoskin TL, Stallings-Mann ML, Degnim AC, Radisky DC, Frost MH, Vierkant RA, Hartmann LC, Visscher DW.

Breast Cancer Res Treat. 2015 May;151(1):89-97. doi: 10.1007/s10549-015-3370-y. Epub 2015 Apr 12.

24.

Flat epithelial atypia and risk of breast cancer: A Mayo cohort study.

Said SM, Visscher DW, Nassar A, Frank RD, Vierkant RA, Frost MH, Ghosh K, Radisky DC, Hartmann LC, Degnim AC.

Cancer. 2015 May 15;121(10):1548-55. doi: 10.1002/cncr.29243. Epub 2015 Jan 13.

25.

Model for individualized prediction of breast cancer risk after a benign breast biopsy.

Pankratz VS, Degnim AC, Frank RD, Frost MH, Visscher DW, Vierkant RA, Hieken TJ, Ghosh K, Tarabishy Y, Vachon CM, Radisky DC, Hartmann LC.

J Clin Oncol. 2015 Mar 10;33(8):923-9. doi: 10.1200/JCO.2014.55.4865. Epub 2015 Jan 26.

26.

Spatial analysis of paediatric swimming pool submersions by housing type.

Shenoi RP, Levine N, Jones JL, Frost MH, Koerner CE, Fraser JJ Jr.

Inj Prev. 2015 Aug;21(4):245-53. doi: 10.1136/injuryprev-2014-041397. Epub 2015 Jan 9.

PMID:
25575965
27.

Clinical characteristics of breast cancers in African-American women with benign breast disease: a comparison to the surveillance, epidemiology, and end results program.

Mitro SD, Ali-Fehmi R, Bandyopadhyay S, Alosh B, Albashiti B, Radisky DC, Frost MH, Degnim AC, Ruterbusch JJ, Cote ML.

Breast J. 2014 Nov-Dec;20(6):571-7. doi: 10.1111/tbj.12331. Epub 2014 Sep 8.

28.

Impact of reconstruction and reoperation on long-term patient-reported satisfaction after contralateral prophylactic mastectomy.

Boughey JC, Hoskin TL, Hartmann LC, Johnson JL, Jacobson SR, Degnim AC, Frost MH.

Ann Surg Oncol. 2015 Feb;22(2):401-8. doi: 10.1245/s10434-014-4053-3. Epub 2014 Sep 6.

29.

Immune cell quantitation in normal breast tissue lobules with and without lobulitis.

Degnim AC, Brahmbhatt RD, Radisky DC, Hoskin TL, Stallings-Mann M, Laudenschlager M, Mansfield A, Frost MH, Murphy L, Knutson K, Visscher DW.

Breast Cancer Res Treat. 2014 Apr;144(3):539-49. doi: 10.1007/s10549-014-2896-8. Epub 2014 Mar 5.

30.

Sclerosing adenosis and risk of breast cancer.

Visscher DW, Nassar A, Degnim AC, Frost MH, Vierkant RA, Frank RD, Tarabishy Y, Radisky DC, Hartmann LC.

Breast Cancer Res Treat. 2014 Feb;144(1):205-12. doi: 10.1007/s10549-014-2862-5. Epub 2014 Feb 8.

31.

Understanding the premalignant potential of atypical hyperplasia through its natural history: a longitudinal cohort study.

Hartmann LC, Radisky DC, Frost MH, Santen RJ, Vierkant RA, Benetti LL, Tarabishy Y, Ghosh K, Visscher DW, Degnim AC.

Cancer Prev Res (Phila). 2014 Feb;7(2):211-7. doi: 10.1158/1940-6207.CAPR-13-0222. Epub 2014 Jan 30.

32.

A brief Patient-Reported Outcomes Quality of Life (PROQOL) instrument to improve patient care.

Ridgeway JL, Beebe TJ, Chute CG, Eton DT, Hart LA, Frost MH, Jensen D, Montori VM, Smith JG, Smith SA, Tan AD, Yost KJ, Ziegenfuss JY, Sloan JA.

PLoS Med. 2013 Nov;10(11):e1001548. doi: 10.1371/journal.pmed.1001548. Epub 2013 Nov 12.

33.

Spiritual quality of life in advanced cancer patients receiving radiation therapy.

Piderman KM, Johnson ME, Frost MH, Atherton PJ, Satele DV, Clark MM, Lapid MI, Sloan JA, Rummans TA.

Psychooncology. 2014 Feb;23(2):216-21. doi: 10.1002/pon.3390. Epub 2013 Sep 9.

34.

Caregivers of patients with cancer fatigue: a high level of symptom burden.

Clark MM, Atherton PJ, Lapid MI, Rausch SM, Frost MH, Cheville AL, Hanson JM, Garces YI, Brown PD, Sloan JA, Richardson JW, Piderman KM, Rummans TA.

Am J Hosp Palliat Care. 2014 Mar;31(2):121-5. doi: 10.1177/1049909113479153. Epub 2013 Feb 21.

35.

Spiritual well-being in lung cancer survivors.

Frost MH, Novotny PJ, Johnson ME, Clark MM, Sloan JA, Yang P.

Support Care Cancer. 2013 Jul;21(7):1939-46. doi: 10.1007/s00520-013-1757-z. Epub 2013 Feb 19.

36.

Benign breast disease and the risk of subsequent breast cancer in African American women.

Cote ML, Ruterbusch JJ, Alosh B, Bandyopadhyay S, Kim E, Albashiti B, Sharaf Aldeen B, Radisky DC, Frost MH, Visscher DW, Hartmann LC, Nassar WH, Ali-Femhi R.

Cancer Prev Res (Phila). 2012 Dec;5(12):1375-80. doi: 10.1158/1940-6207.CAPR-12-0175. Epub 2012 Oct 19.

37.

Randomized controlled trial of maintaining quality of life during radiotherapy for advanced cancer.

Clark MM, Rummans TA, Atherton PJ, Cheville AL, Johnson ME, Frost MH, Miller JJ, Sloan JA, Graszer KM, Haas JG, Hanson JM, Garces YI, Piderman KM, Lapid MI, Netzel PJ, Richardson JW, Brown PD.

Cancer. 2013 Feb 15;119(4):880-7. doi: 10.1002/cncr.27776. Epub 2012 Aug 28.

38.

Spiritual well-being and quality of life of women with ovarian cancer and their spouses.

Frost MH, Johnson ME, Atherton PJ, Petersen WO, Dose AM, Kasner MJ, Burger KN, Sloan JA, Pipe TB.

J Support Oncol. 2012 Mar-Apr;10(2):72-80. doi: 10.1016/j.suponc.2011.09.001. Epub 2011 Dec 14. Erratum in: J Support Oncol. 2012 May-Jun;10(3):131.

PMID:
22169704
39.

Contralateral prophylactic mastectomy: long-term consistency of satisfaction and adverse effects and the significance of informed decision-making, quality of life, and personality traits.

Frost MH, Hoskin TL, Hartmann LC, Degnim AC, Johnson JL, Boughey JC.

Ann Surg Oncol. 2011 Oct;18(11):3110-6. doi: 10.1245/s10434-011-1917-7. Epub 2011 Sep 27.

40.

p16(INK4a) expression and breast cancer risk in women with atypical hyperplasia.

Radisky DC, Santisteban M, Berman HK, Gauthier ML, Frost MH, Reynolds CA, Vierkant RA, Pankratz VS, Visscher DW, Tlsty TD, Hartmann LC.

Cancer Prev Res (Phila). 2011 Dec;4(12):1953-60. doi: 10.1158/1940-6207.CAPR-11-0282. Epub 2011 Sep 15.

41.

Histologic findings in normal breast tissues: comparison to reduction mammaplasty and benign breast disease tissues.

Degnim AC, Visscher DW, Hoskin TL, Frost MH, Vierkant RA, Vachon CM, Shane Pankratz V, Radisky DC, Hartmann LC.

Breast Cancer Res Treat. 2012 May;133(1):169-77. doi: 10.1007/s10549-011-1746-1. Epub 2011 Sep 1.

42.

Estrogen receptor expression in atypical hyperplasia: lack of association with breast cancer.

Barr FE, Degnim AC, Hartmann LC, Radisky DC, Boughey JC, Anderson SS, Vierkant RA, Frost MH, Visscher DW, Reynolds C.

Cancer Prev Res (Phila). 2011 Mar;4(3):435-44. doi: 10.1158/1940-6207.CAPR-10-0242. Epub 2011 Jan 5.

43.

Independent association of lobular involution and mammographic breast density with breast cancer risk.

Ghosh K, Vachon CM, Pankratz VS, Vierkant RA, Anderson SS, Brandt KR, Visscher DW, Reynolds C, Frost MH, Hartmann LC.

J Natl Cancer Inst. 2010 Nov 17;102(22):1716-23. doi: 10.1093/jnci/djq414. Epub 2010 Oct 29.

44.

Contralateral prophylactic mastectomy is associated with a survival advantage in high-risk women with a personal history of breast cancer.

Boughey JC, Hoskin TL, Degnim AC, Sellers TA, Johnson JL, Kasner MJ, Hartmann LC, Frost MH.

Ann Surg Oncol. 2010 Oct;17(10):2702-9. doi: 10.1245/s10434-010-1136-7. Epub 2010 Sep 19.

45.

Evaluation of the Tyrer-Cuzick (International Breast Cancer Intervention Study) model for breast cancer risk prediction in women with atypical hyperplasia.

Boughey JC, Hartmann LC, Anderson SS, Degnim AC, Vierkant RA, Reynolds CA, Frost MH, Pankratz VS.

J Clin Oncol. 2010 Aug 1;28(22):3591-6. doi: 10.1200/JCO.2010.28.0784. Epub 2010 Jul 6.

46.

Pseudoangiomatous stromal hyperplasia and breast cancer risk.

Degnim AC, Frost MH, Radisky DC, Anderson SS, Vierkant RA, Boughey JC, Pankratz VS, Ghosh K, Hartmann LC, Visscher DW.

Ann Surg Oncol. 2010 Dec;17(12):3269-77. doi: 10.1245/s10434-010-1170-5. Epub 2010 Jun 22.

47.

Novel breast tissue feature strongly associated with risk of breast cancer.

McKian KP, Reynolds CA, Visscher DW, Nassar A, Radisky DC, Vierkant RA, Degnim AC, Boughey JC, Ghosh K, Anderson SS, Minot D, Caudill JL, Vachon CM, Frost MH, Pankratz VS, Hartmann LC.

J Clin Oncol. 2009 Dec 10;27(35):5893-8. doi: 10.1200/JCO.2008.21.5079. Epub 2009 Oct 5.

48.

Ki67: a time-varying biomarker of risk of breast cancer in atypical hyperplasia.

Santisteban M, Reynolds C, Barr Fritcher EG, Frost MH, Vierkant RA, Anderson SS, Degnim AC, Visscher DW, Pankratz VS, Hartmann LC.

Breast Cancer Res Treat. 2010 Jun;121(2):431-7. doi: 10.1007/s10549-009-0534-7. Epub 2009 Sep 23.

49.

Phase I trial of autologous hematopoietic SCT with escalating doses of topotecan combined with CY and carboplatin in patients with relapsed or persistent ovarian or primary peritoneal carcinoma.

Litzow MR, Peethambaram PP, Safgren SL, Keeney GL, Ansell SM, Dispenzieri A, Elliott MA, Gastineau DA, Gertz MA, Inwards DJ, Lacy MQ, Micallef IN, Porrata LF, Lingle WL, Hartmann LC, Frost MH, Barrette BA, Long HJ, Suman VJ, Reid JM, Ames MM, Kaufmann SH.

Bone Marrow Transplant. 2010 Mar;45(3):490-7. doi: 10.1038/bmt.2009.181. Epub 2009 Aug 3.

50.

Centering prayer for women receiving chemotherapy for recurrent ovarian cancer: a pilot study.

Johnson ME, Dose AM, Pipe TB, Petersen WO, Huschka M, Gallenberg MM, Peethambaram P, Sloan J, Frost MH.

Oncol Nurs Forum. 2009 Jul;36(4):421-8. doi: 10.1188/09.ONF.421-428.

PMID:
19581232

Supplemental Content

Loading ...
Support Center